P3 Health Partners (PIII) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Aug, 2026Market opportunity and industry trends
Operating in a $1.2T Medicare Advantage and FFS Medicare market, with 135K total lives and 106K at-risk lives across six states, including new entries in Nebraska and North Carolina in 2026.
Medicare Advantage now covers 55% of Medicare beneficiaries, representing 35M people and a structural shift in the market.
Value-based care has created a $4T+ spending gap below projected trends, demonstrating its effectiveness in controlling costs.
Industry consolidation, payor cost pressures, and macro tailwinds are expanding the partnership pipeline and addressable market.
Business model and operational strategy
Physician-led, value-based care model enables providers to transition from fee-for-service to risk-based contracts, improving outcomes and lowering costs.
Fully delegated risk model leverages data, AI-enabled insights, and technology for better clinical outcomes and cost management.
Four operational pillars: population targeting, tech-enabled operations, provider enablement, and scalable value creation.
Integrated patient journey coordinates care, aligns incentives, and assumes full financial risk for members.
Financial performance and guidance
Structural improvements in 2025, including renegotiated payer arrangements and leaner operations, have reset the financial baseline for 2026.
2026 guidance: $1.5B–$1.6B in revenue, $260M–$300M medical margin, and $80M–$110M adjusted EBITDA, with a midpoint raised to $95M.
Revenue and margin growth driven by contract restructuring, bid optimization, and operational execution.
New Nebraska market expected to contribute $30M revenue initially, with a glidepath to $300M+ as full risk is assumed.
Latest events from P3 Health Partners
- Q2 2026 delivered strong profitability, raised guidance, but ongoing liquidity risks persist.PIII
Q2 2026 - All four shareholder proposals were approved, with no questions raised by stockholders.PIII
AGM 2026 - Q1 2026 delivered $3M net income and $26M adjusted EBITDA, but liquidity risks remain.PIII
Q1 2026 - 2026 guidance targets $1.5B–$1.65B revenue and $20M–$60M adjusted EBITDA amid strategic growth.PIII
Investor presentation - Key votes include director elections, auditor ratification, and approval of new share issuance.PIII
Proxy filing - Revenue up 26% but net loss widened to $102.9M; liquidity risks remain.PIII
Q3 2024 - Q2 revenue up 15% to $379M, but profitability declined and liquidity risks persist.PIII
Q2 2024 - Q1 2025 saw revenue and membership decline, improved MLR, and ongoing liquidity risks.PIII
Q1 2025 - 2025 guidance reaffirmed with profitability expected, despite a deeper 2024 net loss.PIII
Q4 2024